SANOFI (SAN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock
77.53 EUR
-1.46 (-1.85%)
Taking everything into account, SAN scores 4 out of 10 in our fundamental rating. SAN was compared to 54 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of SAN while its profitability can be described as average. SAN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- SAN had positive earnings in the past year.
- In the past 5 years SAN has always been profitable.
- In the past 5 years SAN always reported a positive cash flow from operatings.
1.2 Ratios
- SAN has a better Return On Assets (10.63%) than 75.93% of its industry peers.
- With a decent Return On Equity value of 18.84%, SAN is doing good in the industry, outperforming 62.96% of the companies in the same industry.
- SAN has a Return On Invested Capital of 13.40%. This is in the better half of the industry: SAN outperforms 64.81% of its industry peers.
- SAN had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 13.93%.
- The 3 year average ROIC (7.31%) for SAN is below the current ROIC(13.40%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROIC | 13.4% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
- With a decent Profit Margin value of 20.63%, SAN is doing good in the industry, outperforming 77.78% of the companies in the same industry.
- SAN's Profit Margin has improved in the last couple of years.
- SAN has a Operating Margin (23.61%) which is comparable to the rest of the industry.
- SAN's Operating Margin has improved in the last couple of years.
- SAN has a Gross Margin (72.29%) which is comparable to the rest of the industry.
- SAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SAN is still creating some value.
- Compared to 1 year ago, SAN has about the same amount of shares outstanding.
- Compared to 5 years ago, SAN has about the same amount of shares outstanding.
- SAN has a better debt/assets ratio than last year.
2.2 Solvency
- SAN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
- With a decent Debt to Equity ratio value of 0.18, SAN is doing good in the industry, outperforming 75.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACC1.74
WACC7.72%
2.3 Liquidity
- SAN has a Current Ratio of 1.06. This is a normal value and indicates that SAN is financially healthy and should not expect problems in meeting its short term obligations.
- SAN's Current ratio of 1.06 is on the low side compared to the rest of the industry. SAN is outperformed by 72.22% of its industry peers.
- SAN has a Quick Ratio of 1.06. This is a bad value and indicates that SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of SAN (0.30) is worse than 90.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 |
3. Growth
3.1 Past
- The earnings per share for SAN have decreased by -5.35% in the last year.
- SAN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
- SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
- SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
- The Earnings Per Share is expected to grow by 7.41% on average over the next years.
- SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.47% yearly.
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 10.20, the valuation of SAN can be described as very reasonable.
- Compared to the rest of the industry, the Price/Earnings ratio of SAN indicates a rather cheap valuation: SAN is cheaper than 85.19% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of SAN to the average of the S&P500 Index (27.38), we can say SAN is valued rather cheaply.
- SAN is valuated reasonably with a Price/Forward Earnings ratio of 9.12.
- Based on the Price/Forward Earnings ratio, SAN is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
- When comparing the Price/Forward Earnings ratio of SAN to the average of the S&P500 Index (24.29), we can say SAN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.2 | ||
| Fwd PE | 9.12 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SAN indicates a somewhat cheap valuation: SAN is cheaper than 70.37% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.56 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SAN does not grow enough to justify the current Price/Earnings ratio.
- SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.3
PEG (5Y)2
EPS Next 2Y5.23%
EPS Next 3Y5.91%
5. Dividend
5.1 Amount
- No dividends for SAN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:SAN (1/20/2026, 3:30:14 PM)
77.53
-1.46 (-1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap188.32B
Revenue(TTM)66.91B
Net Income(TTM)13.80B
Analysts79.31
Price Target101.26 (30.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-5.92%
PT rev (3m)-7.67%
EPS NQ rev (1m)-3.33%
EPS NQ rev (3m)-9.74%
EPS NY rev (1m)-0.63%
EPS NY rev (3m)-1.68%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.2 | ||
| Fwd PE | 9.12 | ||
| P/S | 2.81 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.57 | ||
| P/tB | 42.84 | ||
| EV/EBITDA | 10.56 |
EPS(TTM)7.6
EY9.8%
EPS(NY)8.5
Fwd EY10.97%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.54
BVpS30.16
TBVpS1.81
PEG (NY)4.3
PEG (5Y)2
Graham Number71.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROCE | 16.17% | ||
| ROIC | 13.4% | ||
| ROICexc | 14.75% | ||
| ROICexgc | 65.74% | ||
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% | ||
| FCFM | N/A |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-ScoreN/A
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.68 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 | ||
| Altman-Z | N/A |
F-ScoreN/A
WACC7.72%
ROIC/WACC1.74
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
EBIT growth 1Y9.12%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.1%
EBIT Next 3Y13.19%
EBIT Next 5Y10.5%
FCF growth 1Y-19.94%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SAN.PA FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 4 / 10 to SAN.PA.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SAN.PA) has a profitability rating of 6 / 10.
What is the valuation of SANOFI based on its PE and PB ratios?
The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 10.2 and the Price/Book (PB) ratio is 2.57.
How financially healthy is SANOFI?
The financial health rating of SANOFI (SAN.PA) is 3 / 10.